News

Will bridge critical gaps in care for people of color with moderate to severe plaque psoriasis.

Data demonstrates efficacy of smart dosing technology.

Industry must act now to minimize effects of COVID-19 on clinical research.

AMCR to utilize ScienceMedia's protocol compliance management solution.

Platform to alleviate logistical challenges with patients.

FDA recently approved the disease-modifying therapy for adults with hemolytic anemia caused by PK (pyruvate kinase) deficiency.

New white paper assess implications of technology on DCTs.

Almost 5% of global drugs trials are conducted in Ukraine and Russia and are now on hold.

Calyx brings medical Imaging, IRT, and EDC solution delivery to ProTrials customers.

FDA compliant operating system to deliver longitudinal health data and patient engagement.

The latest business and people happenings from the past month, all in one place.

Emmes bolsters rare disease research capabilities.

New collaboration will drive diversity in clinical trials.

New facilities and services to meet growing demand for Phase I studies.

MHRA shares CluePoints case study to demonstrate the value of statistical monitoring in clinical trial oversight and monitoring.

Data to inform prevention of sudden cardiac death in the young and pediatric product development.

CRO chosen as provider of medical imaging, IRT, and EDC.

New site to focus on on psychiatric, cannabis, and psychedelic studies.

SMART on FHIR technology to reduce need for manual input of patient data.

New edition of bi-monthly report focuses on cost variation and mis-estimation in clinical trial budgets.

DTRA continues growth.

Remaining Pharmacy Business to support DCTs.

Launch of new consortium includes partnerships with Trialbee and mdgroup.

Upgrades include new enhancements to remote monitoring.

Oncology patients treated with Kite’s YESCARTA® will be monitored remotely to identify signs of potential adverse side effects.

Combined entities to provide solidified hub for DCTs.

New system will help pharma companies ensure clinical trial protocols are compatible with latest AI-enabled site solutions.